Verona Pharma PLC American Depositary Share (VRNA) Competitors $106.16 -0.01 (0.00%) As of 12:49 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock VRNA vs. ONC, INSM, BNTX, TEVA, SMMT, GMAB, VTRS, ASND, RDY, and QGENShould you be buying Verona Pharma PLC American Depositary Share stock or one of its competitors? The main competitors of Verona Pharma PLC American Depositary Share include BeOne Medicines (ONC), Insmed (INSM), BioNTech (BNTX), Teva Pharmaceutical Industries (TEVA), Summit Therapeutics (SMMT), Genmab A/S (GMAB), Viatris (VTRS), Ascendis Pharma A/S (ASND), Dr. Reddy's Laboratories (RDY), and Qiagen (QGEN). These companies are all part of the "pharmaceutical products" industry. Verona Pharma PLC American Depositary Share vs. Its Competitors BeOne Medicines Insmed BioNTech Teva Pharmaceutical Industries Summit Therapeutics Genmab A/S Viatris Ascendis Pharma A/S Dr. Reddy's Laboratories Qiagen BeOne Medicines (NASDAQ:ONC) and Verona Pharma PLC American Depositary Share (NASDAQ:VRNA) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, risk, dividends, earnings, analyst recommendations, institutional ownership and media sentiment. Do analysts prefer ONC or VRNA? BeOne Medicines presently has a consensus price target of $330.89, indicating a potential upside of 2.98%. Verona Pharma PLC American Depositary Share has a consensus price target of $109.00, indicating a potential upside of 2.67%. Given BeOne Medicines' stronger consensus rating and higher possible upside, equities analysts clearly believe BeOne Medicines is more favorable than Verona Pharma PLC American Depositary Share.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BeOne Medicines 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00Verona Pharma PLC American Depositary Share 0 Sell rating(s) 12 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.14 Do insiders & institutionals believe in ONC or VRNA? 48.5% of BeOne Medicines shares are held by institutional investors. Comparatively, 85.9% of Verona Pharma PLC American Depositary Share shares are held by institutional investors. 6.6% of BeOne Medicines shares are held by company insiders. Comparatively, 4.8% of Verona Pharma PLC American Depositary Share shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Does the media refer more to ONC or VRNA? In the previous week, BeOne Medicines and BeOne Medicines both had 11 articles in the media. Verona Pharma PLC American Depositary Share's average media sentiment score of 1.60 beat BeOne Medicines' score of 0.83 indicating that Verona Pharma PLC American Depositary Share is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BeOne Medicines 6 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Verona Pharma PLC American Depositary Share 10 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Which has better valuation and earnings, ONC or VRNA? Verona Pharma PLC American Depositary Share has lower revenue, but higher earnings than BeOne Medicines. BeOne Medicines is trading at a lower price-to-earnings ratio than Verona Pharma PLC American Depositary Share, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBeOne Medicines$4.56B7.72-$644.79M-$1.73-185.73Verona Pharma PLC American Depositary Share$221.67M39.19-$173.42M-$0.99-107.24 Which has more volatility and risk, ONC or VRNA? BeOne Medicines has a beta of 0.21, meaning that its stock price is 79% less volatile than the S&P 500. Comparatively, Verona Pharma PLC American Depositary Share has a beta of 0.14, meaning that its stock price is 86% less volatile than the S&P 500. Is ONC or VRNA more profitable? BeOne Medicines has a net margin of -3.89% compared to Verona Pharma PLC American Depositary Share's net margin of -36.62%. BeOne Medicines' return on equity of -1.22% beat Verona Pharma PLC American Depositary Share's return on equity.Company Net Margins Return on Equity Return on Assets BeOne Medicines-3.89% -1.22% -0.72% Verona Pharma PLC American Depositary Share -36.62%-21.12%-9.07% SummaryBeOne Medicines beats Verona Pharma PLC American Depositary Share on 9 of the 15 factors compared between the two stocks. Get Verona Pharma PLC American Depositary Share News Delivered to You Automatically Sign up to receive the latest news and ratings for VRNA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VRNA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VRNA vs. The Competition Export to ExcelMetricVerona Pharma PLC American Depositary ShareMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.69B$3.10B$5.76B$9.85BDividend YieldN/A2.28%6.66%4.49%P/E Ratio-107.2420.9382.4826.51Price / Sales39.19367.07500.41161.56Price / CashN/A43.5325.7028.92Price / Book32.978.0510.816.51Net Income-$173.42M-$53.35M$3.28B$266.22M7 Day Performance0.27%-0.93%-0.43%-1.21%1 Month Performance0.66%5.97%6.47%3.32%1 Year Performance285.77%10.33%49.57%23.49% Verona Pharma PLC American Depositary Share Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VRNAVerona Pharma PLC American Depositary Share2.5911 of 5 stars$106.170.0%$109.00+2.7%+290.2%$8.69B$221.67M-107.2430News CoveragePositive NewsONCBeOne Medicines0.9642 of 5 stars$306.05+2.7%$330.89+8.1%N/A$33.54B$4.56B-176.9111,000Gap DownINSMInsmed3.7687 of 5 stars$136.10+0.8%$132.57-2.6%+95.8%$28.77B$363.71M-23.841,271Trending NewsAnalyst ForecastAnalyst RevisionBNTXBioNTech1.9431 of 5 stars$100.00-1.9%$135.80+35.8%+14.1%$24.04B$2.88B-62.506,772TEVATeva Pharmaceutical Industries3.5133 of 5 stars$18.41+2.0%$24.71+34.3%+1.3%$21.11B$16.54B-115.0436,830News CoveragePositive NewsSMMTSummit Therapeutics3.3331 of 5 stars$23.70-2.9%$33.31+40.5%+86.7%$17.61B$700K-23.47110News CoverageAnalyst ForecastOptions VolumeGMABGenmab A/S4.0419 of 5 stars$24.87-1.0%$37.60+51.2%-1.2%$15.96B$3.26B12.502,682Positive NewsVTRSViatris1.7973 of 5 stars$10.55+1.3%$10.40-1.4%-11.3%$12.30B$14.12B-3.6432,000ASNDAscendis Pharma A/S3.4465 of 5 stars$194.27+0.2%$243.36+25.3%+48.5%$11.89B$393.54M-37.651,017News CoveragePositive NewsAnalyst ForecastRDYDr. Reddy's Laboratories2.7941 of 5 stars$14.20-0.1%$16.95+19.4%-12.6%$11.85B$3.81B21.5127,811Positive NewsQGENQiagen4.2625 of 5 stars$46.53+0.9%$49.69+6.8%+8.4%$10.34B$2.04B27.495,765Positive News Related Companies and Tools Related Companies ONC Alternatives INSM Alternatives BNTX Alternatives TEVA Alternatives SMMT Alternatives GMAB Alternatives VTRS Alternatives ASND Alternatives RDY Alternatives QGEN Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VRNA) was last updated on 9/4/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWashington prepares for warWhile the headlines obsess over overseas conflicts, Washington has been quietly preparing for something much b...Porter & Company | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredFree: The Crypto Summit That Could Change Your Life27 industry leaders share urgent market intel (free access)... For a very limited time, you can claim your ...Crypto 101 Media | SponsoredThis Massive Market is Ripe for Disruption by this NasdaqFanatics Hit $31B. This Nasdaq Company Is Building the Next Wave Fanatics built a merch empire by owning th...i2i Marketing Group, LLC | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verona Pharma PLC American Depositary Share Please log in to your account or sign up in order to add this asset to your watchlist. Share Verona Pharma PLC American Depositary Share With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
